Kite is dedicated to curing cancer. Learn about the science of cell therapy, our cancer research, and our cancer treatments in the pipeline.

Learn how Kite’s industry-leading cell therapy technology harnesses the power of the immune system to target and attack tumors.

Founded in 2009 and acquired by Gilead Sciences in 2017, Kite has been a pioneer in cell therapy research and leader in the immuno-oncology space.

Learn about Kite’s mission to change the way cancer is treated with cell therapy – the use of genetically modified immune cells programmed to target tumors.

2022年12月7日 · Daiichi Sankyo and Kite have now agreed that the Marketing Authorization for Yescarta will be transferred to Gilead Sciences K.K., the Japan subsidiary of Gilead Sciences, …

Find contact info for Kite. For Kite medical information, clinical trial inquiries, adverse reactions and product questions, contact (844) 454-KITE.

Learn about the cancer therapies in Kite’s pipeline, including cell therapy and immuno-oncology therapies that could transform the way cancer is treated.

Kite has locations around the globe, including our corporate headquarters in Santa Monica, California, our cell therapy manufacturing facilities in El Segundo, California and Frederick, …

Learn about Kite’s innovative therapies that harness the power of the immune system to fight cancer, including information about a specific cancer treatment.

Find the Kite authorized treatment centers (ATCs) around the globe where patients can access CAR T-cell therapy.